Article
Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors
2018-04-18
Abstract excerpt
Targeted therapy for patients with HER2 positive (HER2+) breast cancer has improved the overall survival, but many patients still suffer relapse and death of the disease. Intra-tumor heterogeneity of both estrogen receptor (ER) and HER2 expression has been proposed to play a key role in treatment failure, but little work has been done to comprehensively study this heterogeneity at the single-cell level. In this st...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4ef90697-5d25-526e-ab64-7111cf4a2c78
- DOI
- 10.1101/297549
